Steve Sosnick, Interactive Brokers’ chief strategist, discusses the latest vaccine news from Astra-Zeneca and Oxford University.
With each new vaccine development, the stock market dynamics are changing, according to Sosnick. Here’s why:
Photo Credit: Yuri Samoilov via Flickr Creative Commons
Kimberly Clouse, Private Client Advocate and Chair of Covestor’s Advisory Board, discusses anchoring and prospect theory.
Defensive stocks have had a big run since May, but now is not the time to buy them, says Bill DeShurko, manager of the Dividend and Income Plus model.
Sell signals are multiplying in the stock market as 2016 unfolds
Few investors truly understand the virtual currency and how it works.
